How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/history-of-myocardial-infarction-due-to-atherothrombotic-coronary-artery-disease.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

History of myocardial infarction due to atherothrombotic coronary artery disease — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

History of myocardial infarction due to atherothrombotic coronary artery disease (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating History of myocardial infarction due to atherothrombotic coronary artery disease, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Micardis	TELMISARTAN	Boehringer Ingelheim	Angiotensin 2 Receptor Blocker [EPC]	Type-2 angiotensin II receptor		1998-01-01
Pritor	Pritor	DongKoo Bio & Pharma		ATP-binding cassette sub-family G member 2, Multidrug and toxin extrusion protein 1, Type-2 angiotensin II receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Boehringer Ingelheim · 1 drug in History of myocardial infarction due to atherothrombotic coronary artery disease
DongKoo Bio & Pharma · 1 drug in History of myocardial infarction due to atherothrombotic coronary artery disease

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in History of myocardial infarction due to atherothrombotic coronary artery disease:

Cite this brief

Drug Landscape (2026). History of myocardial infarction due to atherothrombotic coronary artery disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/history-of-myocardial-infarction-due-to-atherothrombotic-coronary-artery-disease. Accessed 2026-06-10.

History of myocardial infarction due to atherothrombotic coronary artery disease full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing